How to buy Applied Genetic Technologies Corporation stock | $4.01

Applied Genetic Technologies Corporation is a biotechnology business based in the US. Applied Genetic Technologies Corporation shares (AGTC) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Genetic Technologies Corporation employs 83 staff and has a market cap (total outstanding shares value) of 0.00.

Applied Genetic Technologies Corporation stock price (NASDAQ: AGTC)

Use our graph to track the performance of AGTC stocks over time.

Applied Genetic Technologies Corporation shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$4.01
52-week range	$3.47 - $9.67
50-day moving average	$4.00
200-day moving average	$4.55
Wall St. target price	$15.78
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.11

Buy Applied Genetic Technologies Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Applied Genetic Technologies Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Applied Genetic Technologies Corporation by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Applied Genetic Technologies Corporation price performance over time

Historical closes compared with the close of $4.01 from 2021-05-28

1 week (2021-07-24)	N/A
1 month (2021-07-02)	-2.67%
3 months (2021-05-04)	3.35%
6 months (2021-01-31)	N/A

1 year (2020-07-31)	N/A
2 years (2019-07-31)	N/A
3 years (2018-07-31)	N/A
5 years (2016-07-31)	N/A

Applied Genetic Technologies Corporation financials

Gross profit TTM	$-13,933,000
Return on assets TTM	-31.54%
Return on equity TTM	-66.21%
Profit margin	0%
Book value	$2.27
Market capitalisation	$156.1 million

TTM: trailing 12 months

Shorting Applied Genetic Technologies Corporation shares

There are currently 4.0 million Applied Genetic Technologies Corporation shares held short by investors – that's known as Applied Genetic Technologies Corporation's "short interest". This figure is 3.1% up from 3.9 million last month.

There are a few different ways that this level of interest in shorting Applied Genetic Technologies Corporation shares can be evaluated.

Applied Genetic Technologies Corporation's "short interest ratio" (SIR)

Applied Genetic Technologies Corporation's "short interest ratio" (SIR) is the quantity of Applied Genetic Technologies Corporation shares currently shorted divided by the average quantity of Applied Genetic Technologies Corporation shares traded daily (recently around 1.8 million). Applied Genetic Technologies Corporation's SIR currently stands at 2.17. In other words for every 100,000 Applied Genetic Technologies Corporation shares traded daily on the market, roughly 2170 shares are currently held short.

However Applied Genetic Technologies Corporation's short interest can also be evaluated against the total number of Applied Genetic Technologies Corporation shares, or, against the total number of tradable Applied Genetic Technologies Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Applied Genetic Technologies Corporation's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Applied Genetic Technologies Corporation shares in existence, roughly 90 shares are currently held short) or 0.1031% of the tradable shares (for every 100,000 tradable Applied Genetic Technologies Corporation shares, roughly 103 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Applied Genetic Technologies Corporation.

Find out more about how you can short Applied Genetic Technologies Corporation stock.

Applied Genetic Technologies Corporation share dividends

We're not expecting Applied Genetic Technologies Corporation to pay a dividend over the next 12 months.

Applied Genetic Technologies Corporation share price volatility

Over the last 12 months, Applied Genetic Technologies Corporation's shares have ranged in value from as little as $3.47 up to $9.67. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Genetic Technologies Corporation's is 2.1877. This would suggest that Applied Genetic Technologies Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Applied Genetic Technologies Corporation overview

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which has completed Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate for the patients with advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and three preclinical programs in targeting central nervous system disorders, including frontotemporal dementia, amyotrophic lateral sclerosis, and adrenoleukodystrophy. It has collaboration agreements with Synpromics Limited; University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was founded in 1999 and is headquartered in Alachua, Florida. .

Frequently asked questions

What percentage of Applied Genetic Technologies Corporation is owned by insiders or institutions?
Currently 0.72% of Applied Genetic Technologies Corporation shares are held by insiders and 57.571% by institutions. How many people work for Applied Genetic Technologies Corporation?
Latest data suggests 83 work at Applied Genetic Technologies Corporation. When does the fiscal year end for Applied Genetic Technologies Corporation?
Applied Genetic Technologies Corporation's fiscal year ends in June. Where is Applied Genetic Technologies Corporation based?
Applied Genetic Technologies Corporation's address is: 14193 NW 119th Terrace, Alachua, FL, United States, 32615 What is Applied Genetic Technologies Corporation's ISIN number?
Applied Genetic Technologies Corporation's international securities identification number is: US03820J1007 What is Applied Genetic Technologies Corporation's CUSIP number?
Applied Genetic Technologies Corporation's Committee on Uniform Securities Identification Procedures number is: 03820J100